注射用血凝酶联合垂体后叶素治疗肺结核咯血的效果
|
摘要
目的分析肺结核咯血患者采用注射用血凝酶与垂体后叶素联合治疗的临床效果及安全性水平。方法选择2016年12月—2017年12月于我院治疗的肺结核咯血患者76例作为研究对象。采用随机数字表法,将其分为实验组与参照组,每组均38例。参照组予以垂体后叶素止血,实验组行注射用血凝酶与垂体后叶素联合治疗,对比两组患者治疗效果、不良反应、复发率及止血时间。结果实验组肺结核咯血临床治疗总有效率高于参照组;与参照组相比,实验组不良反应发生率较低,实验组止血时间短于参照组;与参照组相比,实验组治疗后咯血复发比例较低,组间比较,差异均具有统计学意义(P <0.05)。结论注射用血凝酶与垂体后叶素联合治疗效果较好。
Objective To analyze the clinical efficacy and safety of batroxol combined with pituitrin in the treatment of pulmonary tuberculosis with hemoptysis. Methods 76 patients with pulmonary tuberculosis hemoptysis treated in our hospital from December 2016 to December 2017 were selected as the study subjects. Random number table method was used to divide them into experimental group and reference group, 38 cases in each group. The control group was treated with Pituitrin to stop bleeding. The experimental group was treated with batroxtin and pituitrin. The therapeutic effect, adverse reactions, recurrence rate and hemostasis time of the two groups were compared. Results The total effective rate of clinical treatment of pulmonary tuberculosis hemoptysis in the experimental group was higher than that in the control group. Compared with the control group,the incidence of adverse reactions in the experimental group was lower,and the hemostasis time in the experimental group was shorter than that in the control group. Compared with the control group, the recurrence rate of hemoptysis in the experimental group was lower after treatment, and the difference between the two groups was statistically significant(P < 0.05).Conclusion The combination of batroxobin and pituitrin is effective.
Objective To analyze the clinical efficacy and safety of batroxol combined with pituitrin in the treatment of pulmonary tuberculosis with hemoptysis. Methods 76 patients with pulmonary tuberculosis hemoptysis treated in our hospital from December 2016 to December 2017 were selected as the study subjects. Random number table method was used to divide them into experimental group and reference group, 38 cases in each group. The control group was treated with Pituitrin to stop bleeding. The experimental group was treated with batroxtin and pituitrin. The therapeutic effect, adverse reactions, recurrence rate and hemostasis time of the two groups were compared. Results The total effective rate of clinical treatment of pulmonary tuberculosis hemoptysis in the experimental group was higher than that in the control group. Compared with the control group,the incidence of adverse reactions in the experimental group was lower,and the hemostasis time in the experimental group was shorter than that in the control group. Compared with the control group, the recurrence rate of hemoptysis in the experimental group was lower after treatment, and the difference between the two groups was statistically significant(P < 0.05).Conclusion The combination of batroxobin and pituitrin is effective.
引文
[1]刘道恒,仵倩红.巴曲亭联合垂体后叶素治疗肺结核咯血的临床疗效观察[J].中国煤炭工业医学杂志,2016,19(3):382-384.
[2]余威勇.巴曲亭联合氨甲环酸治疗肺结核伴中小量咯血效果观察[J].中国乡村医药,2015,22(19):22-23.
[3]朱时宝,李勋光,陈冲.注射用血凝酶与垂体后叶素联合治疗支气管扩张大咯血的疗效观察[J].临床合理用药杂志,2016,9(29):36-37.
[4]阮文锋,武文娟.酚妥拉明与垂体后叶素联合治疗肺结核顽固性咯血疗效研究[J].中国现代药物应用,2016,10(14):119-120.
[5]曾家副,陈玉强,黄慧.普鲁卡因针联合脑垂体后叶素治疗咯血疗效观察[J].淮海医药,2016,34(3):325-326.
[6]干小红,龙霞.垂体后叶素联合酚妥拉明治疗肺结核咯血的疗效及安全性的系统评价[J].中国医院药学杂志,2016,36(5):386-391.
[7]邹昵.垂体后叶素联合酚妥拉明治疗支气管扩张大咯血的疗效分析[J].中国处方药,2016,14(4):86-87.
[8]陈辉灵,何浩斌.酚妥拉明联合垂体后叶素治疗老年支气管扩张伴大咯血的疗效分析[J].中国现代药物应用,2016,10(8):23-24.
[9]栾利文.酚妥拉明和垂体后叶素联合法治疗肺结核咯血临床疗效和安全性观察[J].黑龙江医药,2016,29(3):444-445.
[10]袁萍萍.垂体后叶素治疗肺结核咯血的临床分析[J].中国医药指南,2016,14(26):57.
[11]余汉光,郑小河,张桂冬,等.5例垂体后叶素治疗肺结核大咯血致严重水中毒昏迷的临床探讨[J].齐齐哈尔医学院学报,2016,37(21):2673-2674.
[12]马依努尔·肉孜.静脉输液泵泵入垂体后叶素联合酚妥拉明治疗肺结核咯血的临床效果观察[J].中国生化药物杂志,2017,37(10):73-74.
[2]余威勇.巴曲亭联合氨甲环酸治疗肺结核伴中小量咯血效果观察[J].中国乡村医药,2015,22(19):22-23.
[3]朱时宝,李勋光,陈冲.注射用血凝酶与垂体后叶素联合治疗支气管扩张大咯血的疗效观察[J].临床合理用药杂志,2016,9(29):36-37.
[4]阮文锋,武文娟.酚妥拉明与垂体后叶素联合治疗肺结核顽固性咯血疗效研究[J].中国现代药物应用,2016,10(14):119-120.
[5]曾家副,陈玉强,黄慧.普鲁卡因针联合脑垂体后叶素治疗咯血疗效观察[J].淮海医药,2016,34(3):325-326.
[6]干小红,龙霞.垂体后叶素联合酚妥拉明治疗肺结核咯血的疗效及安全性的系统评价[J].中国医院药学杂志,2016,36(5):386-391.
[7]邹昵.垂体后叶素联合酚妥拉明治疗支气管扩张大咯血的疗效分析[J].中国处方药,2016,14(4):86-87.
[8]陈辉灵,何浩斌.酚妥拉明联合垂体后叶素治疗老年支气管扩张伴大咯血的疗效分析[J].中国现代药物应用,2016,10(8):23-24.
[9]栾利文.酚妥拉明和垂体后叶素联合法治疗肺结核咯血临床疗效和安全性观察[J].黑龙江医药,2016,29(3):444-445.
[10]袁萍萍.垂体后叶素治疗肺结核咯血的临床分析[J].中国医药指南,2016,14(26):57.
[11]余汉光,郑小河,张桂冬,等.5例垂体后叶素治疗肺结核大咯血致严重水中毒昏迷的临床探讨[J].齐齐哈尔医学院学报,2016,37(21):2673-2674.
[12]马依努尔·肉孜.静脉输液泵泵入垂体后叶素联合酚妥拉明治疗肺结核咯血的临床效果观察[J].中国生化药物杂志,2017,37(10):73-74.